Thursday, 3 October 2013

Ireland Pharmaceuticals and Healthcare Report Q4 2013

Business Monitor International Market Research Reports
Market Reports Online XML Feed 
Marketing on a budget?

Join the waiting list for our newest ebook on How to Run Ads on an Entrepreneur's Budget.
From our sponsors
Ireland Pharmaceuticals and Healthcare Report Q4 2013
Oct 2nd 2013, 00:00

Price: $ 1295  

BMI View: A number of negative developments this quarter have led us to downgrade our pharmaceutical and healthcare forecasts. The establishment of a 'preferred drugs' list and implementation of the Health (Pricing and Supply of Medical Goods) Bill shows the government's determination to exact cost savings from pharmaceutical companies. While these initiatives will benefit generic drugmakers, the Irish Pharmacy Union has voiced concerns that current medicine shortages will be exacerbated as a result. Headline Expenditure Projections ? Pharmaceuticals: EUR2.17bn (US$2.75bn) in 2012 to EUR2.02bn (US$2.69bn) in 2013; -6.7 % in local currency terms and -2.2% in US dollar terms. Forecast downgraded slightly from previous quarter. ? Healthcare: EUR14.02bn (US$17.81bn) in 2012 to EUR13.49bn (US$17. ...

Complete report details with Table of Contents and more @

Delicious Digg Evernote Facebook Google Bookmarks Google Plus LinkedIn StumbleUpon Tumblr Twitter
You are receiving this email because you subscribed to this feed at

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

No comments:

Post a Comment